Cargando…
Eculizumab as rescue therapy in severe resistant lupus nephritis
Autores principales: | Pickering, Matthew C., Ismajli, Mediola, Condon, Marie B., McKenna, Nicola, Hall, Angela E., Lightstone, Liz, Terence Cook, H., Cairns, Thomas D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643725/ https://www.ncbi.nlm.nih.gov/pubmed/26316577 http://dx.doi.org/10.1093/rheumatology/kev307 |
Ejemplares similares
-
Altered expression of signalling lymphocyte activation molecule receptors in T-cells from lupus nephritis patients—a potential biomarker of disease activity
por: Stratigou, Victoria, et al.
Publicado: (2017) -
Immune gene expression and functional networks in distinct lupus nephritis classes
por: Gilmore, Alyssa C, et al.
Publicado: (2022) -
Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis
por: Wilson, Hannah R., et al.
Publicado: (2019) -
Positive antineutrophil cytoplasmic antibody serology in patients with lupus nephritis is associated with distinct histopathologic features on renal biopsy
por: Turner-Stokes, Tabitha, et al.
Publicado: (2017) -
Atypical Hemolytic Uremic Syndrome Secondary to Lupus Nephritis,
Responsive to Eculizumab
por: Raufi, Alexander G., et al.
Publicado: (2016)